Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2026-01-25 @ 9:04 AM
Study NCT ID:
NCT03604692
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2018-07-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Sponsor:
Syndax Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SNDX-6352-0503
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None